Page last updated: 2024-09-04

olmesartan and Coronary Disease

olmesartan has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Haller, H; Ito, S; Izzo, JL; Januszewicz, A; Katayama, S; Menne, J; Mimran, A; Rabelink, TJ; Ritz, E; Ruilope, LM; Rump, LC; Viberti, G	1

Trials

1 trial(s) available for olmesartan and Coronary Disease

Article	Year
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. The New England journal of medicine, 2011, Mar-10, Volume: 364, Issue:10 Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Imidazoles; Male; Middle Aged; Tetrazoles; Young Adult	2011

Article

Year

Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.

The New England journal of medicine, 2011, Mar-10, Volume: 364, Issue:10

Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Imidazoles; Male; Middle Aged; Tetrazoles; Young Adult

2011